John Y O'Brien

Zaiput Flow Technologies LLC, located in Waltham, MA, specializes in advanced phase separation and extraction technologies, providing innovative solutions for liquid-liquid and gas-liquid separation applications. Their product offerings include production scale separators, extraction platforms, and optimization services tailored to enhance liquid-liquid extraction and partition chromatography processes. With a focus on technological development, Zaiput serves various industries through its cutting-edge solutions in heterogeneous catalysis and pressure regulation. The company is committed to providing customer support and training resources while actively engaging in partnerships and collaborations worldwide. Generated from the website

The Lins Institute of Science, located in Waltham, Massachusetts, is dedicated to investigating Earth's space environment, particularly the dynamic interactions between the ionosphere and thermosphere in the Low Earth Orbit (LEO) region. Their research aims to enhance understanding of satellite drag dynamics, especially during periods of magnetic activity that impact orbit determination and laser communication applications. By analyzing satellite data, the institute seeks to improve the specification and forecasting of the satellite drag environment, addressing the challenges posed by environmental disturbances. Their work is crucial for advancing technology and ensuring effective communication in the ever-evolving landscape of space science. Generated from the website

Onward Medical Inc, based in Lexington, MA, is a pioneering company dedicated to developing innovative therapies for individuals with spinal cord injuries and Parkinson's disease. Their flagship product, the ARCEX System, is the first approved non-invasive spinal cord stimulation system designed to enhance hand sensation and strength for those with chronic cervical spinal cord injuries. The company is led by a diverse team of scientists, engineers, and physicians, all committed to creating life-changing therapies. With numerous FDA Breakthrough Device Designation awards and a robust portfolio of patents, Onward Medical continues to focus on safety and effectiveness in its clinical trials, demonstrating significant improvements in quality of life for participants. Generated from the website